Axxam, a Milan-based contract research organization, addressed paper record-keeping challenges in early-stage drug discovery—such as compliance risks, inefficiency, and poor data traceability—by implementing Revvity Signals Notebook. The electronic lab notebook improved accuracy, efficiency, and compliance with robust audit trails, searchable archives, and seamless collaboration for internal and external teams. This digital transition enhanced data integrity, accelerated workflows, reduced resource demands, and provided real-time visibility, enabling Axxam to strengthen quality processes and drive faster innovation in life sciences research.

Join for free to read